SOURCE: Antisoma plc

March 02, 2006 07:07 ET

Antisoma to present at SG Cowen Conference on 6 March 2006

LONDON -- (MARKET WIRE) -- March 2, 2006 --

02 March 2006, London, UK - Cancer drug developer Antisoma plc (LSE: ASM; USOTC: ATSMY) today announces that Chief Executive Officer, Glyn Edwards, will be presenting at the 26th SG Cowen Annual Healthcare conference, Boston, Mass., USA.

Mr Edwards's presentation is scheduled for 4.50pm EST on Monday, March 6, with an additional breakout session at 5.40pm. A webcast of the presentation will be available to all on Antisoma's website at

It is recommended that viewers log on 15 minutes early in order to register and download any necessary software. If you are unable to participate during the live web cast, a recorded replay of the presentation will be available for 90 days.


Margherita Lupi              +44 (0)20 8799 8200
Communications Manager
Antisoma plc
Background on Antisoma

Antisoma is a biopharmaceutical company that develops novel products for the treatment of cancer. Antisoma fills its development pipeline by acquiring promising new product candidates from internationally recognised academic or cancer research institutions. Its core activity is the preclinical and clinical development of these drug candidates. Antisoma has a broad strategic alliance with Roche to develop and commercialise products from its pipeline. Please visit for further information.

Copyright © Hugin ASA 2006. All rights reserved.

Contact Information